Camlin Fine Sciences Limited
Infinity Direct Holdings, promoter of Camlin Fine Sciences, declared no new encumbrance on its shares for the financial year ended March 31, 2026. This regulatory filing confirms compliance with Takeover Regulations.
Apr 28 2026 17:04:00
Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Camlin Fine Sciences promoter Ashish Subhash Dandekar released a total of 40.96 lakh equity shares that were previously pledged. This transaction reduces the promoter's encumbered holding to 7.78% of the total share capital, from an initial 9.92%.
Apr 21 2026 17:04:00
Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Camlin Fine Sciences' promoter, Ashish S. Dandekar, pledged an additional 37.5 lakh equity shares (1.95% of total capital) on April 7 and April 8, 2026. This increases the total pledged shares to 1.905 crore shares, representing 9.92% of the company's total share capital, with 96.32% of promoter's holding now encumbered.
Apr 15 2026 12:04:00
Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Camlin Fine Sciences' promoter, Ashish S. Dandekar, pledged an additional 37.5 lakh equity shares (1.95% of total capital) on April 7 and April 8, 2026. This increases the total pledged shares to 1.905 crore shares, representing 9.92% of the company's total share capital, with 96.32% of promoter's holding now encumbered.
Apr 15 2026 12:04:00
Camlin Fine Sciences Limited
Camlin Fine Sciences received an Income Tax demand of ₹5.47 crore for AY 2023-24, related to Arm's Length Price adjustment for international/domestic transactions. The company plans to appeal the order, stating no financial or operational impact.
Apr 10 2026 16:04:00
Camlin Fine Sciences Ltd - 532834 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Camlin Fine Sciences promoter Ashish Subhash Dandekar pledged 6,50,000 equity shares (0.34%) with Ashika Credit Capital Limited. This pledge serves as additional margin for covering a shortfall in security cover related to financial assistance obtained by the company.
Apr 10 2026 10:04:00
Camlin Fine Sciences Ltd - 532834 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Camlin Fine Sciences promoter Ashish Subhash Dandekar pledged 6,50,000 equity shares (0.34%) with Ashika Credit Capital Limited. This pledge serves as additional margin for covering a shortfall in security cover related to financial assistance obtained by the company.
Apr 10 2026 10:04:00
Camlin Fine Sciences Limited
Camlin Fine Sciences announced a postal ballot seeking shareholder approval to increase its Authorized Share Capital and amend the Memorandum of Association. Remote e-voting is available from April 8, 2026, to May 7, 2026.
Apr 08 2026 12:04:00
Camlin Fine Sciences Ltd - 532834 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Camlin Fine Sciences is seeking shareholder approval for an increase in authorized share capital and amendment to its Memorandum of Association. The approval is via postal ballot with e-voting from April 8, 2026, to May 7, 2026. Results will be declared by May 9, 2026.
Apr 08 2026 12:04:00
Camlin Fine Sciences Ltd - 532834 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Camlin Fine Sciences seeks shareholder approval for an Ordinary Resolution to increase its authorized share capital from ₹21.50 crores to ₹25 crores. This move aims to provide flexibility for future equity fundraising initiatives like QIPs or Rights Issues.
Apr 07 2026 10:04:00
Read More